Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler 50/250 µg/Dose Products and Seretide Diskus 50/250 µg/Dose in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 09 Apr 2018
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Acronyms SAIMI
- Sponsors Orion Pharma
- 05 Apr 2018 Status changed from recruiting to completed.
- 19 Sep 2017 Status changed from not yet recruiting to recruiting.
- 07 Aug 2017 New trial record